scispace - formally typeset
R

Rene Ratschmann

Researcher at Medical University of Vienna

Publications -  9
Citations -  407

Rene Ratschmann is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Guanidinoacetate N-methyltransferase & Substrate reduction therapy. The author has an hindex of 7, co-authored 9 publications receiving 366 citations. Previous affiliations of Rene Ratschmann include University of Vienna & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry.

TL;DR: Both hematocrit and position of the disk within the dried blood spot have a significant and sometimes additive effect on levels of AA, AC and GAA in dried blood spots.
Journal ArticleDOI

Long-Term Stability of Amino Acids and Acylcarnitines in Dried Blood Spots

TL;DR: Estimation of the annual decrease of metabolites may allow for the retrospective diagnosis of inborn errors of metabolism in filter cards that have been stored for long periods of time.
Journal ArticleDOI

Simplified Newborn Screening Protocol for Lysosomal Storage Disorders

TL;DR: Turboflow online sample cleanup and the use of an additional analytical column enabled the implementation of lysosomal storage disorder testing in a nationwide screening program while keeping the total analysis time to <2 min per sample.
Journal ArticleDOI

The National Austrian Newborn Screening Program - Eight years experience with mass spectrometry. Past, present, and future goals

TL;DR: The National Austrian Newborn Screening Program for inherited metabolic and endocrinologic disorders was introduced in 1966 and continuously evolved by expanding the screening panel from phenylketonuria and galactosefizienz to congenital hypothyreose, biotinidopathy and cystische Fibrose.
Journal ArticleDOI

Transcobalamin II deficiency at birth.

TL;DR: Interestingly, urinary methylmalonic acid excretion was increased significantly during the first days of life suggesting that functional cobalamin deficiency is present also during fetal life, although not giving rise to clinical symptoms until well after birth.